Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells
Authors:
- Yoshiki YanagawaYYYoshiki Yanagawa
- Machiko MatsumotoMMMachiko Matsumoto
- Hiroko TogashiHTHiroko Togashi
- 1 October 2011
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 25 (7) , 1427-1433
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Decreased Soluble Adenylyl Cyclase Activity in Cystic Fibrosis Is Related to Defective Apical Bicarbonate Exchange and Affects Ciliary Beat Frequency RegulationJournal of Biological Chemistry, 2010
- The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptorsBritish Journal of Pharmacology, 2010
- Expression and regulation of interleukin‐33 in human monocytesImmunology, 2010
- Social stress and asthma: The role of corticosteroid insensitivityJournal of Allergy and Clinical Immunology, 2010
- RETRACTED: The cytokine interleukin-33 mediates anaphylactic shockProceedings of the National Academy of Sciences, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences, 2009
- Structure of Epac2 in complex with a cyclic AMP analogue and RAP1BNature, 2008
- The rush to adrenaline: drugs in sport acting on the β‐adrenergic systemBritish Journal of Pharmacology, 2008
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsProceedings of the National Academy of Sciences, 2007